ArticleJournal of nematology2012
Optimization of a Host Diet for in vivo Production of Entomopathogenic Nematodes.
Article in Journal of nematology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 11 citations in OpenAlex.
- Entomopathogenic nematode production and application technology.Journal of nematology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To facilitate improved in vivo culture of entomopathogenic nematodes, production of both insect hosts and nematodes should be optimized for maximum fitness, quality, and cost efficiency. In previous studies, we developed an improved diet for Tenebrio molitor, a host that is used for in vivo nematode production, and we demonstrated that single insect diet components (e.g., lipids and proteins) can have a positive or negative impact on entomopathogenic nematode fitness and quality. In this study, we tested components of our improved T. molitor diet (lipids, cholesterol, and a salt [MnSO4]) alone and in combination for effects on host susceptibility and reproductive capacity of Heterorhabditis indica and Steinernema carpocapsae. Our results indicated that moderate levels of lipids (10%) increased host susceptibility to S. carpocapsae but did not affect H. indica, whereas cholesterol and MnSO4 increased host susceptibility to H. indica but not S. carpocapsae. The combined T. molitor diet (improved for increased insect growth) increased host susceptibility to S. carpocapsae and had a neutral effect on H. indica; interactions among single diet ingredients were observed. No effects of insect host diet were detected on the reproductive capacity of either nematode species in T. molitor. Subsequently, progeny infective juveniles, derived from nematodes grown in T. molitor that were fed diets with varying nutritive components were tested for virulence to and reproduction capacity in the target pest Diaprepes abbreviatus. The progeny nematodes produced from differing T. molitor diet treatments did not differ in virulence except H. indica derived from a diet that lacked cholesterol or MnS04 (but contained lipids) did not cause significant D. abbreviatus suppression relative to the water control. We conclude that the improved insect host diet is compatible with production of H. indica and S. carpocapsae, and increases host susceptibility in S. carpocapsae. Furthermore, in a general sense, our results indicate host diets can be optimized for improved in vivo entomopathogenic nematode production efficiency. This is the first report of an insect diet that was optimized for both host and entomopathogenic nematode production. Additionally, our study indicates that host diet may impact broader aspects of entomopathogenic nematode ecology and pest control efficacy.
Indexed as
Identifiers
23481558PMC3547339W1489471032What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.